From episodes to engagement: India’s next healthcare growth opportunity

India’s healthcare sector has spent the last decade adding capacity, more hospitals, more specialists, and greater surgical volume. What it has not changed is how it counts value. A consultation, a procedure, a hospital stay remains the basic unit around which much of the business is built.

The relationship with the same patient over five years, 10 years or a lifetime is not counted in the same way, even though it can create value far beyond a single intervention. That is the opportunity ahead: building value across the patient relationship rather than around each treatment episode alone.

 This is not an argument for eliminating treatment, or a rebrand of the familiar claim that prevention beats cure. A patient in a continuous care relationship may still need surgery, a diagnosis and, sometimes, a hospital bed. Treatment remains central to the system. What changes is that treatment becomes one part of a longer relationship rather than the entire transaction.

 The economics of this shift are less straightforward than the argument that early care costs less than late care. The harder question is who pays for acting early and who benefits later. A patient may avoid a more serious treatment burden, an insurer may pay fewer claims, an employer may lose fewer working days, and a hospital may see lower demand for high-acuity care. The benefits are spread across the system, but the cost of acting early often sits with one payer at one point in time.

That is a difficult equation for a healthcare business to solve, and one reason prevention and continuous care have been easier to endorse in principle than to build into the economics of the system.

A continuous healthcare business therefore operates differently. It stays engaged with a patient between consultations. It connects diagnostics to a clinical pathway rather than leaving a result to sit in a report. It treats a consultation as the beginning of follow-up rather than the end of an encounter, and identifies risk earlier, before it develops into an acute episode.

Technology enables this model through connected records, remote consultations, integrated diagnostics and artificial intelligence that can help clinicians identify patterns worth a second look. But the operating model comes first. Continuity becomes valuable because the business is built to sustain a relationship and technology is what makes that possible at scale.

For healthcare businesses, that shift from episodic intervention to earlier and more sustained relevance is where long-term value can be created.

 Insurers and employers sit at the center of this economic argument. An insurer that identifies and manages a member’s risk early may see the financial return gradually through fewer or less severe claims, rather than immediately through a single intervention.

An employer may experience the benefit through fewer sick days, improved productivity and stronger retention, rather than through a line item attached to a single treatment. The opportunity is to develop arrangements in which providers, insurers and employers can share the value created by better long-term outcomes, rather than each paying separately for their own part of the healthcare journey.

 If the model changes, what counts as growth must change with it. Consultation volumes, procedure counts and bed occupancy will remain relevant. Hospitals are not disappearing, but a continuous healthcare business also needs to track how early patients enter a care pathway, whether an identified risk leads to evaluation, how many patients complete follow-up rather than dropping off after one visit, how often referrals are completed, and whether outcomes improve across a patient's full journey rather than within a single admission.

These measures are harder to collect than a bed occupancy rate, but they are essential if healthcare companies are to understand whether they are building lasting value or simply increasing episodic activity.

The value at stake is both clinical and economic. Better longitudinal care can improve outcomes for patients while creating measurable value across the wider healthcare system. India already has evidence that healthcare reach at scale is achievable. More than 1.78 lakh Ayushman Arogya Mandirs are operational across the country. Close to 75 crore people had enrolled in the National Non-Communicable Diseases system by December 2025.

eSanjeevani had delivered more than 49 crore teleconsultations by August 2026. These figures demonstrate India’s ability to extend healthcare access and outreach at a national scale. The next opportunity is to turn that reach into continuity, creating relationships that extend beyond the single point of contact represented by a consultation.

India has already built the capacity to treat at scale. Its next healthcare growth opportunity lies in building continuous relationships with patients and creating value across the full healthcare journey. Organisations that establish those relationships earlier, retain them across different stages of care and demonstrate measurable long-term value will be better positioned for the next phase of India’s healthcare growth.

 (The author is CEO, Birla Fertility and IVF. Views are personal.)